Shi Zuo

4PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 15, 2026
Targeting mitochondrial calcium homeostasis via novel S100A9 inhibitor B2 as a promising agent against AML.

|Mar 28, 2024
NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression.

Shi-Long Zhang, Shen-Jie Zhang, Lian Li

|Feb 11, 2023
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells.

Xiaoqiang Gao, Shi Zuo

|Feb 08, 2022
Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis.

Qian Chen, Sibo Yang, Yewei Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Teng-Xiang Chen